Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial

  1. Ohman, E.M.
  2. Roe, M.T.
  3. Steg, P.G.
  4. James, S.K.
  5. Povsic, T.J.
  6. White, J.
  7. Rockhold, F.
  8. Plotnikov, A.
  9. Mundl, H.
  10. Strony, J.
  11. Sun, X.
  12. Husted, S.
  13. Tendera, M.
  14. Montalescot, G.
  15. Bahit, M.C.
  16. Ardissino, D.
  17. Bueno, H.
  18. Claeys, M.J.
  19. Nicolau, J.C.
  20. Cornel, J.H.
  21. Goto, S.
  22. Kiss, R.G.
  23. Güray, Ü.
  24. Park, D.-W.
  25. Bode, C.
  26. Welsh, R.C.
  27. Gibson, C.M.
  28. Show all authors +
Journal:
The Lancet

ISSN: 1474-547X 0140-6736

Year of publication: 2017

Volume: 389

Issue: 10081

Pages: 1799-1808

Type: Article

DOI: 10.1016/S0140-6736(17)30751-1 GOOGLE SCHOLAR